(Q36750162)

16 August 2017

1 reference

title

Targeted delivery of antitumoral therapy to glioma and other malignancies with synthetic chlorotoxin (TM-601). (English)

1 reference

16 August 2017

Adam N Mamelak

1

1 reference

16 August 2017

Douglas B Jacoby

series ordinal

2

1 reference

16 August 2017

language of work or name

English

0 references

publication date

1 March 2007

1 reference

Expert Opinion on Drug Delivery

16 August 2017

published in

1 reference

16 August 2017

volume

4

1 reference

16 August 2017

issue

2

1 reference

16 August 2017

page(s)

175-186

1 reference

Epidemiology and etiology of gliomas

16 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.2.175

Progress in long-term survival in adult patients with supratentorial low-grade gliomas: a population-based study of 993 patients in whom tumors were diagnosed between 1970 and 1993

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.2.175

Clinical prognostic factors in patients with malignant glioma treated with combined modality approach.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.2.175

Factors influencing survival in high-grade gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.2.175

Imaging-based stereotaxic serial biopsies in untreated intracranial glial neoplasms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.2.175

Fluorescence-guided resection of glioblastoma multiforme by using 5-aminolevulinic acid-induced porphyrins: a prospective study in 52 consecutive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.2.175

Intraoperative infrared imaging of brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.2.175

Diffusion-tensor imaging of white matter tracts in patients with cerebral neoplasm.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.2.175

Extent of resection in malignant gliomas: a critical summary

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.2.175

Near complete surgical resection predicts a favorable outcome in pediatric patients with nonbrainstem, malignant gliomas: results from a single center in the magnetic resonance imaging era.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.2.175

Current management of glioblastoma multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.2.175

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.2.175

Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas. The Polymer-brain Tumor Treatment Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.2.175

Biodegradable polymer implants to treat brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.2.175

A phase III clinical evaluation of herpes simplex virus type 1 thymidine kinase and ganciclovir gene therapy as an adjuvant to surgical resection and radiation in adults with previously untreated glioblastoma multiforme.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.2.175

A phase 1-2 clinical trial of gene therapy for recurrent glioblastoma multiforme by tumor transduction with the herpes simplex thymidine kinase gene followed by ganciclovir. GLI328 European-Canadian Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.2.175

Phase I study of adenoviral delivery of the HSV-tk gene and ganciclovir administration in patients with current malignant brain tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.2.175

Stereotactic injection of DTI-015 into recurrent malignant gliomas: phase I/II trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.2.175

Chemotherapy administered in conjunction with osmotic blood-brain barrier modification in patients with brain metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.2.175

Intracarotid infusion of RMP-7, a bradykinin analog, and transport of gallium-68 ethylenediamine tetraacetic acid into human gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.2.175

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.2.175

Intracarotid chemotherapy with etoposide and cisplatin for malignant brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.2.175

Intra-arterial BCNU chemotherapy for treatment of malignant gliomas of the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.2.175

Convection-enhanced delivery of adeno-associated virus type 2 (AAV2) into the striatum and transport of AAV2 within monkey brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.2.175

Targeted therapy for brain tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.2.175

Convection-enhanced delivery of paclitaxel for the treatment of recurrent malignant glioma: a phase I/II clinical study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.2.175

Convection-enhanced and local delivery of targeted cytotoxins in the treatment of malignant gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.2.175

Intracranial therapy of glioblastoma with the fusion protein DTAT in immunodeficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.2.175

EGFRvIII as a promising target for antibody-based brain tumor therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.2.175

Phase II trial of murine (131)I-labeled antitenascin monoclonal antibody 81C6 administered into surgically created resection cavities of patients with newly diagnosed malignant gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.2.175

Direct injection of 90Y MoAbs into glioma tumor resection cavities leads to limited diffusion of the radioimmunoconjugates into normal brain parenchyma: a model to estimate absorbed radiation dose

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.2.175

Expression of voltage-activated chloride currents in acute slices of human gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.2.175

Chlorotoxin, a scorpion-derived peptide, specifically binds to gliomas and tumors of neuroectodermal origin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.2.175

Chlorotoxin inhibits glioma cell invasion via matrix metalloproteinase-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.2.175

A role for ion channels in glioma cell invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.2.175

A Phase I/II Study of Herpes Simplex Virus Type 1 Thymidine Kinase “Suicide” Gene Therapy for Recurrent Glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.2.175

21 January 2018

Identifiers

DOI

10.1517/17425247.4.2.175

1 reference

16 August 2017

1 reference